These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 15456245)

  • 1. Rationale, design, and synthesis of novel phenyl imidazoles as opioid receptor agonists for gastrointestinal disorders.
    Breslin HJ; Miskowski TA; Rafferty BM; Coutinho SV; Palmer JM; Wallace NH; Schneider CR; Kimball ES; Zhang SP; Li J; Colburn RW; Stone DJ; Martinez RP; He W
    J Med Chem; 2004 Oct; 47(21):5009-20. PubMed ID: 15456245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of opioid ligands possessing mixed micro agonist/delta antagonist activity among pyridomorphinans derived from naloxone, oxymorphone, and hydromorphone [correction of hydropmorphone].
    Ananthan S; Khare NK; Saini SK; Seitz LE; Bartlett JL; Davis P; Dersch CM; Porreca F; Rothman RB; Bilsky EJ
    J Med Chem; 2004 Mar; 47(6):1400-12. PubMed ID: 14998329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LPK-26, a novel kappa-opioid receptor agonist with potent antinociceptive effects and low dependence potential.
    Tao YM; Li QL; Zhang CF; Xu XJ; Chen J; Ju YW; Chi ZQ; Long YQ; Liu JG
    Eur J Pharmacol; 2008 Apr; 584(2-3):306-11. PubMed ID: 18353307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. JNJ-20788560 [9-(8-azabicyclo[3.2.1]oct-3-ylidene)-9H-xanthene-3-carboxylic acid diethylamide], a selective delta opioid receptor agonist, is a potent and efficacious antihyperalgesic agent that does not produce respiratory depression, pharmacologic tolerance, or physical dependence.
    Codd EE; Carson JR; Colburn RW; Stone DJ; Van Besien CR; Zhang SP; Wade PR; Gallantine EL; Meert TF; Molino L; Pullan S; Razler CM; Dax SL; Flores CM
    J Pharmacol Exp Ther; 2009 Apr; 329(1):241-51. PubMed ID: 19151246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 4-Phenyl-4-[1H-imidazol-2-yl]-piperidine derivatives, a novel class of selective delta-opioid agonists.
    Trabanco AA; Pullan S; Alonso JM; Alvarez RM; Andrés JI; Boeckx I; Fernández J; Gómez A; Iturrino L; Janssens FE; Leenaerts JE; De Lucas AI; Matesanz E; Meert T; Steckler T
    Bioorg Med Chem Lett; 2006 Jan; 16(1):146-9. PubMed ID: 16236510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biological evaluation of 14-alkoxymorphinans. 18. N-substituted 14-phenylpropyloxymorphinan-6-ones with unanticipated agonist properties: extending the scope of common structure-activity relationships.
    Greiner E; Spetea M; Krassnig R; Schüllner F; Aceto M; Harris LS; Traynor JR; Woods JH; Coop A; Schmidhammer H
    J Med Chem; 2003 Apr; 46(9):1758-63. PubMed ID: 12699394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unique high-affinity synthetic mu-opioid receptor agonists with central- and systemic-mediated analgesia.
    Okada Y; Tsuda Y; Fujita Y; Yokoi T; Sasaki Y; Ambo A; Konishi R; Nagata M; Salvadori S; Jinsmaa Y; Bryant SD; Lazarus LH
    J Med Chem; 2003 Jul; 46(15):3201-9. PubMed ID: 12852751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of a novel bivalent morphinan possessing kappa agonist and micro agonist/antagonist properties.
    Mathews JL; Peng X; Xiong W; Zhang A; Negus SS; Neumeyer JL; Bidlack JM
    J Pharmacol Exp Ther; 2005 Nov; 315(2):821-7. PubMed ID: 16076937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and biological evaluation of 14-alkoxymorphinans. 22.(1) Influence of the 14-alkoxy group and the substitution in position 5 in 14-alkoxymorphinan-6-ones on in vitro and in vivo activities.
    Lattanzi R; Spetea M; Schüllner F; Rief SB; Krassnig R; Negri L; Schmidhammer H
    J Med Chem; 2005 May; 48(9):3372-8. PubMed ID: 15857143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel diastereomeric opioid tetrapeptides exhibit differing pharmacological activity profiles.
    Ioja E; Tourwé D; Kertész I; Tóth G; Borsodi A; Benyhe S
    Brain Res Bull; 2007 Sep; 74(1-3):119-29. PubMed ID: 17683797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parallel methods for the preparation and SAR exploration of N-ethyl-4-[(8-alkyl-8-aza-bicyclo[3.2.1]oct-3-ylidene)-aryl-methyl]-benzamides, powerful mu and delta opioid agonists.
    Coats SJ; Schulz MJ; Carson JR; Codd EE; Hlasta DJ; Pitis PM; Stone DJ; Zhang SP; Colburn RW; Dax SL
    Bioorg Med Chem Lett; 2004 Nov; 14(22):5493-8. PubMed ID: 15482911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and characterization of potent and selective mu-opioid receptor antagonists, [Dmt(1), D-2-Nal(4)]endomorphin-1 (Antanal-1) and [Dmt(1), D-2-Nal(4)]endomorphin-2 (Antanal-2).
    Fichna J; do-Rego JC; Chung NN; Lemieux C; Schiller PW; Poels J; Broeck JV; Costentin J; Janecka A
    J Med Chem; 2007 Feb; 50(3):512-20. PubMed ID: 17266203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and preliminary in vitro investigation of bivalent ligands containing homo- and heterodimeric pharmacophores at mu, delta, and kappa opioid receptors.
    Peng X; Knapp BI; Bidlack JM; Neumeyer JL
    J Med Chem; 2006 Jan; 49(1):256-62. PubMed ID: 16392810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of substitution on the pyrrole N atom in derivatives of tetrahydronaltrindole, tetrahydrooxymorphindole, and a related 4,5-epoxyphenylpyrrolomorphinan.
    Srivastava SK; Shefali S; Miller CN; Aceto MD; Traynor JR; Lewis JW; Husbands SM
    J Med Chem; 2004 Dec; 47(26):6645-8. PubMed ID: 15588100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. mu- but not delta- and kappa-opioid receptors in the ventrolateral orbital cortex mediate opioid-induced antiallodynia in a rat neuropathic pain model.
    Zhao M; Wang JY; Jia H; Tang JS
    Brain Res; 2006 Mar; 1076(1):68-77. PubMed ID: 16476416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of potent phenyl imidazoles as opioid receptor agonists.
    Breslin HJ; Cai C; Miskowski TA; Coutinho SV; Zhang SP; Hornby P; He W
    Bioorg Med Chem Lett; 2006 May; 16(9):2505-8. PubMed ID: 16483774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N,N-Diethyl-4-[(3-hydroxyphenyl)(piperidin-4-yl)amino] benzamide derivatives: the development of diaryl amino piperidines as potent delta opioid receptor agonists with in vivo anti-nociceptive activity in rodent models.
    Jones P; Griffin AM; Gawell L; Lavoie R; Delorme D; Roberts E; Brown W; Walpole C; Xiao W; Boulet J; Labarre M; Coupal M; Butterworth J; St-Onge S; Hodzic L; Salois D
    Bioorg Med Chem Lett; 2009 Nov; 19(21):5994-8. PubMed ID: 19800791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The roles of different subtypes of opioid receptors in mediating the nucleus submedius opioid-evoked antiallodynia in a neuropathic pain model of rats.
    Wang JY; Zhao M; Yuan YK; Fan GX; Jia H; Tang JS
    Neuroscience; 2006; 138(4):1319-27. PubMed ID: 16472929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antinociceptive and adverse effects of mu- and kappa-opioid receptor agonists: a comparison of morphine and U50488-H.
    Gallantine EL; Meert TF
    Basic Clin Pharmacol Toxicol; 2008 Nov; 103(5):419-27. PubMed ID: 18699797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The novel compound (+/-)-1-[10-((E)-3-Phenyl-allyl)-3,10-diaza-bicyclo[4.3.1]dec-3-yl]-propan-1-one (NS7051) attenuates nociceptive transmission in animal models of experimental pain; a pharmacological comparison with the combined mu-opioid receptor agonist and monoamine reuptake inhibitor tramadol.
    Munro G; Baek CA; Erichsen HK; Nielsen AN; Nielsen EØ; Scheel-Kruger J; Weikop P; Peters D
    Neuropharmacology; 2008 Feb; 54(2):331-43. PubMed ID: 18037451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.